Literature DB >> 26018857

Selective recruitment of host factors by HSV-1 replication centers.

Feng-Chao Lang1, Xin Li1, Olga Vladmirova2, Zhuo-Ran Li1, Gui-Jun Chen3, Yu Xiao3, Li-Hong Li3, Dan-Feng Lu1, Hong-Bo Han4, Ju-Min Zhou5.   

Abstract

Herpes simplex virus type 1 (HSV-1) enters productive infection after infecting epithelial cells, where it controls the host nucleus to make viral proteins, starts viral DNA synthesis and assembles infectious virions. In this process, replicating viral genomes are organized into replication centers to facilitate viral growth. HSV-1 is known to use host factors, including host chromatin and host transcription regulators, to transcribe its genes; however, the invading virus also encounters host defense and stress responses to inhibit viral growth. Recently, we found that HSV-1 replication centers recruit host factor CTCF but exclude γH2A.X. Thus, HSV-1 replication centers may selectively recruit cellular factors needed for viral growth, while excluding host factors that are deleterious for viral transcription or replication. Here we report that the viral replication centers selectively excluded modified histone H3, including heterochromatin mark H3K9me3, H3S10P and active chromatin mark H3K4me3, but not unmodified H3. We found a dynamic association between the viral replication centers and host RNA polymerase II. The centers also recruited components of the DNA damage response pathway, including 53BP1, BRCA1 and host antiviral protein SP100. Importantly, we found that ATM kinase was needed for the recruitment of CTCF to the viral centers. These results suggest that the HSV-1 replication centers took advantage of host signaling pathways to actively recruit or exclude host factors to benefit viral growth.

Entities:  

Keywords:  CTCF; HSV-1; RNA Pol II; Viral replication cente; γH2AX

Mesh:

Substances:

Year:  2015        PMID: 26018857      PMCID: PMC4790689     

Source DB:  PubMed          Journal:  Dongwuxue Yanjiu        ISSN: 0254-5853


  66 in total

1.  RNA polymerase II holoenzyme modifications accompany transcription reprogramming in herpes simplex virus type 1-infected cells.

Authors:  H L Jenkins; C A Spencer
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 2.  Interactions of viruses with the cellular DNA repair machinery.

Authors:  Matthew D Weitzman; Christian T Carson; Rachel A Schwartz; Caroline E Lilley
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

3.  The herpes simplex virus 1 UL41 gene-dependent destabilization of cellular RNAs is selective and may be sequence-specific.

Authors:  Audrey Esclatine; Brunella Taddeo; Linton Evans; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

4.  CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus.

Authors:  G N Filippova; C P Thienes; B H Penn; D H Cho; Y J Hu; J M Moore; T R Klesert; V V Lobanenkov; S J Tapscott
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

5.  Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.

Authors:  S D Showalter; M Zweig; B Hampar
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

6.  Increasing relative prevalence of HSV-2 infection among men with genital ulcers from a mining community in South Africa.

Authors:  W Lai; C Y Chen; S A Morse; Ye Htun; H G Fehler; H Liu; R C Ballard
Journal:  Sex Transm Infect       Date:  2003-06       Impact factor: 3.519

7.  Recruitment of cellular recombination and repair proteins to sites of herpes simplex virus type 1 DNA replication is dependent on the composition of viral proteins within prereplicative sites and correlates with the induction of the DNA damage response.

Authors:  Dianna E Wilkinson; Sandra K Weller
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8.

Authors:  Travis J Taylor; David M Knipe
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes.

Authors:  Roger D Everett; George Sourvinos; Claire Leiper; J Barklie Clements; Anne Orr
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 10.  The herpes simplex virus VP16-induced complex: the makings of a regulatory switch.

Authors:  Joanna Wysocka; Winship Herr
Journal:  Trends Biochem Sci       Date:  2003-06       Impact factor: 13.807

View more
  4 in total

1.  Mutational pressure by host APOBEC3s more strongly affects genes expressed early in the lytic phase of herpes simplex virus-1 (HSV-1) and human polyomavirus (HPyV) infection.

Authors:  Maxwell Shapiro; Laurie T Krug; Thomas MacCarthy
Journal:  PLoS Pathog       Date:  2021-04-30       Impact factor: 6.823

2.  The Ubx Polycomb response element bypasses an unpaired Fab-8 insulator via cis transvection in Drosophila.

Authors:  Danfeng Lu; Zhuoran Li; Lingling Li; Liping Yang; Guijun Chen; Deying Yang; Yue Zhang; Vikrant Singh; Sheryl Smith; Yu Xiao; Erlin Wang; Yunshuang Ye; Wei Zhang; Lei Zhou; Yikang Rong; Jumin Zhou
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

3.  Cohesin promotes HSV-1 lytic transcription by facilitating the binding of RNA Pol II on viral genes.

Authors:  Xin Li; Yafen Yu; Fengchao Lang; Guijun Chen; Erlin Wang; Lihong Li; Zhuoran Li; Liping Yang; Xia Cao; Nigel W Fraser; Jumin Zhou
Journal:  Virol J       Date:  2021-01-23       Impact factor: 4.099

4.  Visualizing the replicating HSV-1 virus using STED super-resolution microscopy.

Authors:  Zhuoran Li; Ce Fang; Yuanyuan Su; Hongmei Liu; Fengchao Lang; Xin Li; Guijun Chen; Danfeng Lu; Jumin Zhou
Journal:  Virol J       Date:  2016-04-09       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.